Source: Medical Device Network

Neuronix: Neuronix reports positive clinical study results of neuroAD Therapy System for Alzheimer's disease

Israel-based medical device company Neuronix has reported positive results from its clinical study of the neuroAD Therapy System to treat mild to moderate Alzheimer's disease.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Eyal Baror's photo - CEO of Neuronix

CEO

Eyal Baror

CEO Approval Rating

70/100

Read more